STOCK TITAN
MARKET LEADERS
#1 JANX leads with +470% February 2024

JANX (Janux Therapeutics, Inc.) is the best performing stock in February 2024. Following are SOUN (+334%) and VANI (+306%). Top performing sectors: Financial Services (+107% avg, 2 in top 10), Healthcare (+95% avg, 6 in top 10), Real Estate (+94% avg).

Top Stock Gainers February 2024 - Monthly Performance Ranked

Track the top performing stocks of February 2024 ranked by monthly price gain. See which stock gainers delivered the highest gains this month, with market caps over $100 million on Nasdaq and NYSE.

Best performing large-cap stocks in February 2024

MSTR Strategy Inc +103.15% $35.47B
ARM Arm Holdings plc +100% $287.96B
CVNA Carvana Co. +78.53% $70.35B
COIN Coinbase Global, Inc. +57.86% $42.27B
LI Li Auto Inc. +57.39% $12.27B
2024

This ranking shows the top performing stocks and biggest stock gainers during February 2024, calculated from the first to the last trading day of the month. It shows which stocks are going up this month, with split-adjusted data used for consistent performance calculations.

Monthly performance rankings can reveal price strength, sustained momentum, sector rotation, and event-driven moves that are not visible in one-day movers lists. The table is informational only and does not recommend any stock to buy, sell, or hold.

February 2024 Stock Market Momentum

This page answers a current-month trend question with data: which NYSE and NASDAQ stocks have shown the strongest price gains so far in February 2024. The ranking is based on observed market performance, not analyst ratings, price targets, or investment recommendations.

Use the list to research momentum, market breadth, sector strength, and catalysts behind large moves. Before acting on any stock, review the company's news, SEC filings, liquidity, volatility, and your own risk constraints.

Looking for a specific Symbol?

Data as of July 21, 2026 at 7:51 AM EDT

Rank
Symbol
Company Name
Feb Gain
Market Cap
Price
Country
Sector
1
469.85%
978.80 M
$ 16.05
United States
Healthcare
2
333.92%
2.75 B
$ 6.31
United States
Technology
3
305.77%
116.42 M
$ 1.35
United States
Healthcare
4
291.59%
950.69 M
$ 60.07
United States
Financial Services
5
221.71%
4.22 B
$ 36.38
United States
Healthcare
6
216.07%
1.00 B
$ 14
United States
Healthcare
7
203.66%
156.17 M
$ 2.47
United States
Healthcare
8
177.01%
236.69 M
$ 5.01
United States
Technology
9
173.93%
509.18 M
$ 2.72
Hong Kong
Financial Services
10
155.12%
304.73 M
$ 5.19
United States
Healthcare
11
123.9%
709.43 M
$ 105.9
United States
Healthcare
12
114.25%
405.37 M
$ 1.7
China
Consumer Defensive
13
110.43%
127.53 M
$ 32.38
United States
Healthcare
14
110.07%
2.38 B
$ 16.77
United States
Healthcare
15
110.05%
1.80 B
$ 60.65
United States
Healthcare
16
103.68%
783.99 M
$ 6.33
Germany
Consumer Cyclical
17
103.64%
1.35 B
$ 2.82
United States
Technology
18
103.15%
35.47 B
$ 97.82
United States
Technology
19
102.56%
1.60 B
$ 5.58
United States
Healthcare
20
101.09%
6.19 B
$ 16.72
United States
Technology
21
100%
287.96 B
$ 269.61
United Kingdom
Technology
22
100%
3.70 B
$ 14.42
United States
Financial Services
23
99.56%
170.36 M
$ 1.75
United States
Industrials
24
99.43%
122.05 M
$ 1.2
United States
Industrials
25
99.04%
213.73 M
$ 5.57
United States
Technology
26
97.39%
2.24 B
$ 5.02
United States
Healthcare
27
95.76%
396.78 M
$ 7.69
United States
Healthcare
28
94.64%
119.56 M
$ 0.855
United States
Technology
29
93.57%
6.40 B
$ 30.16
United States
Real Estate
30
92.58%
512.96 M
$ 3.54
Sweden
Consumer Cyclical
31
91.67%
397.87 M
$ 3.83
United States
Healthcare
32
91.62%
1.91 B
$ 8.71
United States
Healthcare
33
89.97%
395.83 M
$ 3.58
United States
Healthcare
34
89.08%
107.37 M
$ 1.29
United States
Communication Services
35
81.99%
5.70 B
$ 82.52
United States
Technology
36
78.53%
70.35 B
$ 64.14
United States
Consumer Cyclical
37
76.6%
450.23 M
$ 1.33
United States
Healthcare
38
74.77%
125.51 M
$ 0.7117
United States
Financial Services
39
74.76%
125.27 M
$ 1.87
Canada
Healthcare
40
73.11%
142.36 M
$ 1.235
Canada
Healthcare
41
72.96%
254.91 M
$ 9.08
United States
Technology
42
72.32%
411.22 M
$ 11.97
United States
Healthcare
43
72.21%
873.84 M
$ 3.14
United States
Healthcare
44
71.43%
142.55 M
$ 2.25
United States
Healthcare
45
71.43%
228.75 M
$ 4.07
United States
Healthcare
46
70.8%
424.28 M
$ 10.96
United States
Industrials
47
70.24%
3.19 B
$ 48.83
United States
Technology
48
69.04%
2.45 B
$ 12.475
United States
Healthcare
49
68.48%
200.88 M
$ 2.21
United States
Healthcare
50
66.97%
633.06 M
$ 3.55
United States
Consumer Cyclical
51
66.67%
428.50 M
$ 4.45
United States
Healthcare
52
63.41%
2.22 B
$ 13.83
United States
Industrials
53
62.69%
306.15 M
$ 12.36
United States
Technology
54
62.28%
189.90 M
$ 7.36
United States
Healthcare
55
60.66%
849.40 M
$ 10.65
United States
Healthcare
56
60.48%
771.47 M
$ 14.27
United States
Communication Services
57
60.47%
369.33 M
$ 6.48
United States
Healthcare
58
60.34%
337.25 M
$ 12.15
United Kingdom
Technology
59
60.13%
766.31 M
$ 3.52
United States
Healthcare
60
59.79%
306.37 M
$ 0.5945
United States
Consumer Defensive
61
59.73%
7.52 B
$ 29.42
United States
Consumer Defensive
62
59.69%
8.32 B
$ 228.28
United States
Industrials
63
58.53%
299.50 M
$ 17.21
United Kingdom
Technology
64
58.53%
411.50 M
$ 9.05
Luxembourg
Consumer Cyclical
65
58.28%
1.72 B
$ 27.68
United States
Healthcare
66
57.98%
822.26 M
$ 2.14
United States
Technology
67
57.86%
42.27 B
$ 160.43
United States
Financial Services
68
57.84%
316.60 M
$ 12.92
United States
Healthcare
69
57.58%
257.29 M
$ 22.16
United States
Healthcare
70
57.39%
12.27 B
$ 12.37
China
Consumer Cyclical
71
57.33%
14.37 B
$ 40.2
Australia
Financial Services
72
56.25%
6.54 B
$ 38.3
United States
Healthcare
73
56.11%
546.93 M
$ 4.94
China
Communication Services
74
54.82%
3.44 B
$ 27.53
United States
Healthcare
75
53.65%
1.85 B
$ 31.055
United States
Healthcare
76
53.58%
323.28 B
$ 134.85
United States
Technology
77
52.71%
416.87 M
$ 5.03
United States
Industrials
78
52.14%
749.97 M
$ 7.66
United States
Industrials
79
52.1%
994.04 M
$ 11.13
United States
Healthcare
80
51.74%
1.43 B
$ 38.37
United States
Technology
81
51.56%
766.24 M
$ 29.43
United States
Financial Services
82
51.53%
2.36 B
$ 22.71
United States
Healthcare
83
50.94%
338.49 M
$ 40.88
United States
Healthcare
84
50.83%
1.86 B
$ 26.03
United States
Consumer Cyclical
85
50.74%
201.16 M
$ 11.76
United States
Healthcare
86
50.68%
100.03 M
$ 0.4035
Australia
Industrials
87
50.08%
579.74 M
$ 11.09
United States
Healthcare
88
49.5%
89.40 B
$ 99.28
United States
Financial Services
89
49.41%
2.71 B
$ 26.33
United States
Healthcare
90
48.81%
655.55 M
$ 5.88
United States
Healthcare
91
48.75%
11.13 B
$ 30.99
United States
Technology
92
48.44%
15.41 B
$ 23.83
United States
Technology
93
48.18%
1.34 B
$ 8.61
United States
Technology
94
48.08%
439.29 M
$ 7.97
United States
Basic Materials
95
48.05%
4.33 B
$ 11.34
United States
Healthcare
96
47.11%
2.51 B
$ 22.16
United States
Healthcare
97
46.35%
7.57 B
$ 32.7
United States
Healthcare
98
45.98%
2.20 B
$ 68.8
United States
Technology
99
45.8%
142.64 B
$ 424.6
United States
Communication Services
100
45.78%
541.91 M
$ 9.44
United States
Consumer Cyclical
For the most accurate results, consider cross-referencing our data with other sources.

Frequently Asked Questions

Q Which stock has gained the most in February 2024?
A

JANX (Janux Therapeutics, Inc.) has the highest monthly gain in this ranking for February 2024, with a gain of 470%. Top performers this month include JANX, SOUN, VANI.

Q What stocks gained the most in February 2024?
A

The biggest gainers in February 2024 were: JANX (+470%), SOUN (+334%), VANI (+306%), ROOT (+292%), VKTX (+222%). These monthly rankings show which stocks had the strongest short-term momentum.

Q Does this page recommend the best stocks to buy now?
A

No. This page is an informational ranking of stocks that have already gone up during February 2024. It does not make buy, sell, or hold recommendations and should be used as a research starting point, not financial advice.

Q How can this ranking help explain current stock market trends?
A

The ranking shows where price strength is concentrated during February 2024. Comparing the top gainers by sector, market cap, and recent catalysts can help identify momentum themes and market rotation without implying that any listed stock is a recommendation.

Q Which sectors performed best in February 2024?
A

The top performing sectors in February 2024 included Healthcare, Technology, Financial Services, based on the stocks with highest monthly gains. JANX led the Healthcare sector.

Q How is monthly stock performance calculated?
A

Monthly stock performance is calculated by comparing the closing price on the last trading day of the month to the opening price on the first trading day. Split-adjusted prices ensure accuracy.

Q Where can I find today's top stock gainers and most active stocks?
A

This page ranks stocks by their full-month performance in February 2024. For today's top stock gainers, real-time stock movers, and the most active stocks right now, visit our Momentum Scanner which tracks live intraday market activity across NYSE and NASDAQ.

Understanding Monthly Stock Performance

Monthly performance rankings reveal short-term momentum patterns and help identify stocks experiencing rapid price movements:

  • Momentum Research: Stocks showing strong monthly performance can help identify where market attention and price strength are concentrated.
  • Sector Rotation: Monthly rankings can reveal which sectors are gaining favor with investors and where market leadership is shifting.
  • Event-Driven Moves: Earnings releases, product launches, and regulatory approvals often create significant monthly price movements.

Using Monthly Data Effectively

  • Combine Timeframes: Compare monthly gainers with 52-week and YTD performance to identify stocks with both short and long-term momentum.
  • Research the Catalyst: Investigate why top monthly performers moved significantly. The reason for the move matters as much as the percentage gain.
  • Watch for Reversals: Extreme monthly gains sometimes precede corrections, so treat the ranking as a research starting point rather than a buy list.

Evaluate Your Positions

Researching one of this month's top movers? Use our Stock Return Calculator to review historical performance, or the Position Size Calculator to model position sizing and risk before making your own decision.